Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: J Immunol. 2013 Jan 9;190(3):886–891. doi: 10.4049/jimmunol.1202739

Fig. 4. Serial TLR7 agonist administration drives type I IFN-dependent emergency myelopoiesis.

Fig. 4

(A) Identification of eGMP in WT and IFNARKO mice treated with or without 10 μg gardiquimod i.v. every other day for 6 days. (B) Number of eGMP. Data show 6 mice per group from 2 independent experiments with each dot representing an individual mouse. Significance determined by one-way ANOVA with a tukey post-test.